Sebastian Aguirre

Company: Carbon Biosciences

Job title: Co-Founder & Head of Platform Development

Bio:

Dr. Sebastian Aguirre is the Vice President, Head of Platform at Carbon Biosciences. He has spent nearly two decades studying relevant human and animal viruses, with a focus on the development of vaccines, antivirals, and other virus-derived therapeutics. Before starting Carbon Biosciences, Dr. Aguirre served scientific leadership positions at Synteny Therapeutics and Generation Bio. Formerly, Dr. Aguirre spent eight years in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, New York, where he performed pioneering research on virus and host molecular interaction, coevolution, and viral immune evasion.

Seminars:

Panel Discussion – Viral Vs Non-Viral Delivery Methods: Discussing the Most Appropriate Delivery Methods for Non-Rare Diseases 1:30 pm

Comparing the use of viral and non-viral vectors when delivery gene therapies to prevalent disease targets Discussing advantages and disadvantages of using viral and non-viral delivery methods Analysing the use of LNPs for gene therapies for prevalent diseases Optimizing delivery methods by disease indicationRead more

day: Gene Therapy Beyond Rare Diseases Discussion Day

Development of a Novel Parvovirus-derived Gene Delivery Platform 2:00 pm

Discovering and developing novel autonomous Parovirus as gene therapy vehicles Reducing immune response whilst increasing cargo capacity Harnessing tissue-specific tropism and liver-targeting propertiesRead more

day: Gene Therapy Beyond Rare Diseases Discussion Day